Rhinomed (Rhinomed) YoY EPS Growth : -200.00% (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Rhinomed YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Rhinomed's YoY EPS Growth for the quarter that ended in Jun. 2023 was -200.00%.

Rhinomed's Earnings per Share (Diluted) for the six months ended in Jun. 2023 was $-0.02.

Rhinomed YoY EPS Growth Historical Data

The historical data trend for Rhinomed's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed YoY EPS Growth Chart

Rhinomed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

YoY EPS Growth

Get a 7-Day Free Trial

-10.71

3.23

13.33

46.15

-85.71

Rhinomed Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
YoY EPS Growth	Get a 7-Day Free Trial															-28.57	43.75	44.44	-22.22	-200.00

Rhinomed YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Rhinomed's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EPS Growth (A: Jun. 2023 )
=	(Earnings per Share (Diluted) (A: Jun. 2023 )	-	Earnings per Share (Diluted) (A: Jun. 2022 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2022 ) \|
=	(-0.026	-	-0.014)	/	\| -0.014 \|
=	-85.71 %

Rhinomed's YoY EPS Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EPS Growth (Q: Jun. 2023 )
=	(Earnings per Share (Diluted) (Q: Jun. 2023 )	-	Earnings per Share (Diluted) (Q: Jun. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Jun. 2022 )) \|
=	(-0.015	-	-0.005)	/	\| -0.005 \|
=	-200.00 %

Rhinomed YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Rhinomed's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhinomed (Rhinomed) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (OTCPK:RHNMF) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

RNO:Australia

Address

132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121

Website

https://www.rhinomed.global

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (Rhinomed) Headlines

From GuruFocus

Rhinomed Ltd to Webcast Live at VirtualInvestorConferences.com December 3rd

By PRNewswire PRNewswire • 12-02-2020

Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children

By PRNewswire PRNewswire • 09-07-2021